Trial Profile
A Randomized, Single-Blind, Three-Period Crossover Study Examining the Single Dose Pharmacokinetics of Concomitantly Administered Repaglinide and Metformin Versus Combination Tablet Dosing (NN4440) in Fed Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Repaglinide/metformin (Primary) ; Metformin; Repaglinide
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 16 Dec 2011 New trial record